CAPLIPOINT - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.0
| Stock Code | CAPLIPOINT | Market Cap | 12,320 Cr. | Current Price | 1,622 ₹ | High / Low | 2,397 ₹ |
| Stock P/E | 34.0 | Book Value | 243 ₹ | Dividend Yield | 0.37 % | ROCE | 28.6 % |
| ROE | 22.0 % | Face Value | 2.00 ₹ | DMA 50 | 1,741 ₹ | DMA 200 | 1,893 ₹ |
| Chg in FII Hold | 0.07 % | Chg in DII Hold | -0.05 % | PAT Qtr | 87.3 Cr. | PAT Prev Qtr | 103 Cr. |
| RSI | 33.8 | MACD | -31.8 | Volume | 56,852 | Avg Vol 1Wk | 71,619 |
| Low price | 1,551 ₹ | High price | 2,397 ₹ | PEG Ratio | 1.55 | Debt to equity | 0.00 |
| 52w Index | 8.36 % | Qtr Profit Var | 16.8 % | EPS | 47.7 ₹ | Industry PE | 27.2 |
📊 Analysis: CAPLIPOINT shows weak intraday potential today. Current price (1,622 ₹) is trading below both DMA 50 (1,741 ₹) and DMA 200 (1,893 ₹), reflecting bearish sentiment. RSI at 33.8 indicates the stock is nearing oversold territory, while MACD (-31.8) confirms strong bearish momentum. Volume (56,852) is below the weekly average (71,619), suggesting limited intraday participation.
💰 Optimal Buy Price: 1,600–1,610 ₹ if price stabilizes near support.
📈 Profit Exit Levels: 1,650 ₹ (short-term resistance), 1,700 ₹ (near DMA 50).
📉 Stop-Loss: 1,580 ₹ to protect against downside risk.
⏱️ If Already Holding: Consider exiting intraday if price fails to hold above 1,610 ₹ or if volume remains weak. Profit booking near 1,650–1,700 ₹ is advisable, while a break below 1,580 ₹ should trigger a stop-loss exit.
Positive
- Strong ROCE of 28.6% and ROE of 22% indicate efficient capital usage.
- Debt-free balance sheet (Debt-to-equity: 0.00) reduces financial risk.
- EPS of 47.7 ₹ supports valuation strength.
- Industry PE of 27.2 vs stock PE of 34.0 shows premium positioning in the sector.
Limitation
- High P/E ratio of 34.0 compared to industry average suggests overvaluation.
- Quarterly PAT declined (87.3 Cr vs 103 Cr), showing earnings pressure.
- Weak intraday volume compared to average reduces trading momentum.
- Price significantly below DMA levels signals bearish sentiment.
Company Negative News
- No major negative news reported, but recent profit decline raises concerns.
Company Positive News
- Debt-free status and strong return ratios highlight financial strength.
- Stable institutional holdings with slight FII increase (+0.07%).
Industry
- Pharmaceutical sector remains resilient with steady demand.
- Industry PE at 27.2 indicates moderate valuation compared to CAPLIPOINT’s premium pricing.
Conclusion
⚖️ CAPLIPOINT is a cautious intraday candidate with limited upside due to weak momentum and declining profits. Traders may attempt entries near 1,600–1,610 ₹ with exits around 1,650–1,700 ₹, but strict stop-loss discipline at 1,580 ₹ is essential given bearish indicators.